Capricor Therapeutics, Inc. · 7 hours ago
Material Handler
Capricor Therapeutics is a biotechnology company focused on advancing cell and exosome-based therapies for rare diseases. They are seeking a Material Handler to support manufacturing and logistics operations by managing inventory and processing shipments, ensuring efficient material movement within their facilities.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Receive GMP items into the electronic inventory system, verifying count, vendor item number, and expiration date against specifications and purchase orders before labeling
Pick, pack, and process shipments accurately, ensuring correct identification and quantity
Prepare shipping documents such as bills of lading and process materials against purchase orders and work orders
Physically move materials using handcarts and coordinate with on-site and off-site warehousing facilities
Maintain cleanliness and orderly storage conditions in the warehouse
Perform cycle audits and physical inventory counts; reconcile discrepancies and report findings
Assist in developing and maintaining Standard Operating Procedures (SOPs) for material handling
Collaborate with logistics and manufacturing teams to resolve or prevent material shortages
Train team members as needed and participate in quality and continuous improvement initiatives
Complete basic troubleshooting related to material handling and ensure compliance with work procedures
Qualification
Required
High School Diploma/GED or equivalent
2+ years of experience in material handling, warehousing, or related field
Proficiency in basic mathematics and ability to use hand tools
Basic computer skills, including Windows, Outlook, and Microsoft Office Suite
Strong communication skills and ability to follow instructions
Team-oriented with a sense of ownership and accountability
Preferred
Experience in a GMP-regulated environment
Knowledge of inventory systems and material management software
Familiarity with shipping logistics and documentation
Company
Capricor Therapeutics, Inc.
Capricor Therapeutics is a publicly traded (NASDAQ: CAPR) biotechnology company with a mission to develop groundbreaking therapies that make a meaningful impact on patients’ lives.
Funding
Current Stage
Public CompanyTotal Funding
$329.5MKey Investors
Nippon ShinyakuNational Institutes of HealthCalifornia Institute for Regenerative Medicine
2025-12-05Post Ipo Equity· $150M
2024-10-17Post Ipo Equity· $75M
2024-09-17Post Ipo Equity· $15M
Recent News
2026-01-09
MarketScreener
2025-12-17
Company data provided by crunchbase